Investigation Overview
Investigations on behalf of current investors of Cell Genesys, Inc. (Public, NASDAQ:CEGE), who purchased their shares before June 30, 2009, over possible breaches of fiduciary duty by the board of directors of Cell Genesys, Inc. (Public, NASDAQ:CEGE) was announced. According to the investigations by law firms the investigation focuses on possible breaches of fiduciary duty and other ...
You must register (for free) or login to view the entire investigation.